Co-Authors
This is a "connection" page, showing publications co-authored by Beverly Green and Amanda Petrik.
Connection Strength
2.571
-
Health plan-based mailed fecal testing for colorectal cancer screening among dual-eligible Medicaid/Medicare enrollees: Outcomes of 2 program models. Cancer. 2022 Jan 15; 128(2):410-418.
Score: 0.191
-
Factors Influencing Implementation of a Colorectal Cancer Screening Improvement Program in Community Health Centers: an Applied Use of Configurational Comparative Methods. J Gen Intern Med. 2020 11; 35(Suppl 2):815-822.
Score: 0.179
-
Costs of Two Health Insurance Plan Programs to Mail Fecal Immunochemical Tests to Medicare and Medicaid Plan Members. Popul Health Manag. 2021 04; 24(2):255-265.
Score: 0.175
-
Challenges in assessing population reach in a pragmatic trial. Prev Med Rep. 2019 Sep; 15:100910.
Score: 0.162
-
A cost-effectiveness analysis of a colorectal cancer screening program in safety net clinics. Prev Med. 2019 Mar; 120:119-125.
Score: 0.158
-
Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial. JAMA Intern Med. 2018 Sep 01; 178(9):1174-1181.
Score: 0.154
-
Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers. J Community Health. 2018 02; 43(1):128-136.
Score: 0.148
-
Implementation successes and challenges in participating in a pragmatic study to improve colon cancer screening: perspectives of health center leaders. Transl Behav Med. 2017 09; 7(3):557-566.
Score: 0.144
-
Mapping Multi-Site Clinic Workflows to Design Systems-Enabled Interventions. EGEMS (Wash DC). 2017 Jun 14; 5(1):13.
Score: 0.142
-
The validation of electronic health records in accurately identifying patients eligible for colorectal cancer screening in safety net clinics. Fam Pract. 2016 12; 33(6):639-643.
Score: 0.133
-
Reasons for non-response to a direct-mailed FIT kit program: lessons learned from a pragmatic colorectal-cancer screening study in a federally sponsored health center. Transl Behav Med. 2015 Mar; 5(1):60-7.
Score: 0.121
-
Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials. 2014 Jul; 38(2):344-9.
Score: 0.115
-
Advantages of wordless instructions on how to complete a fecal immunochemical test: lessons from patient advisory council members of a federally qualified health center. J Cancer Educ. 2014 Mar; 29(1):86-90.
Score: 0.113
-
Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes. BMC Cancer. 2014 Feb 26; 14:55.
Score: 0.113
-
Using an Automated Data-driven, EHR-Embedded Program for Mailing FIT kits: Lessons from the STOP CRC Pilot Study. J Gen Pract (Los Angel). 2014 Jan 05; 2.
Score: 0.112
-
What's the "secret sauce"? How implementation variation affects the success of colorectal cancer screening outreach. Implement Sci Commun. 2021 Jan 11; 2(1):5.
Score: 0.045
-
Barriers and Facilitators to Timely Colonoscopy Completion for Safety Net Clinic Patients. Am J Health Behav. 2020 07 01; 44(4):460-472.
Score: 0.044
-
First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders. BMC Health Serv Res. 2020 Feb 21; 20(1):132.
Score: 0.043
-
Prospective Cohort study of Predictors of Follow-Up Diagnostic Colonoscopy from a Pragmatic Trial of FIT Screening. Sci Rep. 2020 02 12; 10(1):2441.
Score: 0.043
-
Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial. Trials. 2020 Jan 15; 21(1):91.
Score: 0.042
-
Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study. Cancer. 2020 02 01; 126(3):540-548.
Score: 0.042
-
Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer. J Gen Intern Med. 2019 Jan 25.
Score: 0.040
-
Two Medicaid health plans' models and motivations for improving colorectal cancer screening rates. Transl Behav Med. 2018 Nov 16.
Score: 0.039
-
Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial. Cancer Med. 2018 Sep; 7(9):4781-4790.
Score: 0.038
-
Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics. BMC Health Serv Res. 2017 06 19; 17(1):411.
Score: 0.035